- Trang chủ
- Phân tích
- Tin tức thị trường
- Company news: Moderna (MRNA) quarterly results solidly beat analysts’ estimates
Tin tức thị trường
03.08.2022
Company news: Moderna (MRNA) quarterly results solidly beat analysts’ estimates
Moderna (MRNA) reported Q2 FY2022 earnings of $5.24 per share (versus $6.46 per share in Q2 FY2021), beating analysts’ consensus estimate of $4.49 per share.
The company’s quarterly revenues amounted to $4.731 bln (+8.7% y/y), beating analysts’ consensus estimate of $3.955 bln.
MRNA rose to $167.50 (+4.16%) in pre-market trading.
Xem thêm